Long-Term Immuno-Response and Risk of Breakthrough Infection After SARS-CoV-2 Vaccination in Kidney Transplantation

QR Code

Long-Term Immuno-Response and Risk of Breakthrough Infection After SARS-CoV-2 Vaccination in Kidney Transplantation

<b>Background</b>: Kidney transplant (KTx) recipients exhibit impaired responses to SARS-CoV-2 vaccination. Correlates of vaccine-induced immunity and risk factors for breakthrough infection are not fully defined. This study evaluated the humoral response trajectories and determinants of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Vincenzo Bellizzi, Mario Fordellone, Carmine Secondulfo, Paolo Chiodini, Giancarlo Bilancio
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Vaccines
Subjects:	kidney transplant COVID SARS-CoV-2 mRNA vaccine BNT162b2 hybrid immunity
Online Access:	https://www.mdpi.com/2076-393X/13/6/566
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety and efficacy of RNA vaccines: State of the art
by: A. V. Blagov, et al.
Published: (2021-11-01)

Nuclear Factor Erythroid 2-Related Factor 2 and SARS-CoV-2 Infection Risk in COVID-19-Vaccinated Hospital Nurses
by: Stefano Rizza, et al.
Published: (2025-07-01)

Effect of recent SARS-CoV-2 infection on anti-spike protein immunoglobulin G II response after BNT162b2 vaccination
by: Daiki Tanno, et al.
Published: (2025-08-01)

Pre-Vaccination Immune Profiles and Responsiveness to Innate Stimuli Predict Reactogenicity and Antibody Magnitude Following mRNA Vaccination
by: Amanda E. Zelkoski, et al.
Published: (2025-07-01)

Comparison of SARS-CoV-2 immune responses following vaccination with Comirnaty (Pfizer) and Vaxzevria (AstraZeneca) in healthy individuals with or without prior SARS-CoV-2 infection
by: Zdzisława Kondera-Anasz, et al.
Published: (2025-07-01)

Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary
by: Shanti Pather, et al.
Published: (2024-12-01)

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
by: Yanping Hu, et al.
Published: (2023-12-01)

The influence of SARS-CoV-2 vaccination on in vitro fertilization outcomes
by: Adi Anis Heusler, et al.
Published: (2025-12-01)

Adverse reactions following first three doses of the BNT162b2 mRNA COVID-19 vaccine: A prospective cohort study on relationships with individual characteristics and previous experience of adverse reactions
by: Ayako Konishi, et al.
Published: (2025-12-01)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
by: A. A. Ilyichev, et al.
Published: (2020-12-01)

Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3
by: Julia N. Faraone, et al.
Published: (2023-12-01)

Breakthrough Infection After a Primary Series of COVID-19 Vaccination Induces Stronger Humoral Immunity and Equivalent Cellular Immunity to the Spike Protein Compared with Booster Shots
by: Yoshifumi Uwamino, et al.
Published: (2025-07-01)

SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study
by: Marlon Yuri Garcia-Paitan, et al.
Published: (2025-07-01)

The mRNA vaccine, a swift warhead against a moving infectious disease target
by: Sheema Mir, et al.
Published: (2024-12-01)

Interaction of SARS-CoV-2 and SARS-CoV-2 vaccines with renin angiotensin aldosterone system, clinical outcomes, and angiotensin (1-7) as a physiological treatment recommendation: hypothesis and theory article
by: Ali Rıza Aktaş
Published: (2025-07-01)

A Novel SARS-CoV-2-Derived Infectious Vector System
by: Ghada Elfayres, et al.
Published: (2025-06-01)

The Coronavirus SARS-Cov-2: the Complexity of Infection Pathogenesis, the Search of Vaccines and Possible Future Pandemics
by: E. P. Kharchenko
Published: (2020-07-01)

Frequency of SARS-CoV-2 RNA Detection in Foreign Medical Students Vaccined against New Coronavirus Infection
by: O. A. Ryabtseva, et al.
Published: (2023-03-01)

Investigating the Interplay of SARS-CoV-2 RNAemia and Peripheral Inflammation in Platelet Dysfunction During Acute SARS-CoV-2 Infection
by: Mariangela Scavone, et al.
Published: (2025-07-01)

SARS-CoV-2 RNA-binding protein suppresses extracellular miRNA release
by: Hyejin Mun, et al.
Published: (2025-12-01)

Single-cell analysis unravels the role of NK cells and monocytes in the control of SARS-CoV-2 breakthrough infections in vaccinated individuals
by: Huiwen Zheng, et al.
Published: (2025-12-01)

Vaccination against the SARS-CoV-2 in individuals with comorbidities
by: S A Berns, et al.
Published: (2025-02-01)

Comparative Analysis of the Diversity of SARS-CoV-2 Lines Circulating in Omsk Region in 2020–2022
by: E. A. Gradoboeva, et al.
Published: (2023-01-01)

A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children
by: Frances Priddy, et al.
Published: (2024-12-01)

SARS-CoV-2 Vaccine Breakthrough Reinfections in Fully Vaccinated Healthcare Workers in Davao City, Philippines: A Retrospective Cohort Study
by: Alfredo A. Hinay, et al.
Published: (2025-07-01)

Immune Durability and Breakthrough Infections 15 Months After SARS-CoV-2 Boosters in People over 65: The IMMERSION Study
by: Concepció Violán, et al.
Published: (2025-07-01)

New SARS-CoV-2 Omicron variant — clinical picture, treatment, prevention (literature review)
by: V. I. Vechorko, et al.
Published: (2022-07-01)

SARS-CoV-2 spike protein mutation variants: Recent advances in theragnostic and vaccines development
by: Jutishna Bora, et al.
Published: (2025-08-01)

International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of 1,000 patients
by: G. P. Arutyunov, et al.
Published: (2020-12-01)

Structural proteins of SARS-CoV-2
by: O. V. Duvanova, et al.
Published: (2023-01-01)

Relationship between SARS-COV-2 And autoimmune neurological diseases
by: A. I. Vlasenko, et al.
Published: (2022-07-01)

Identification of Surface Glycoprotein Mutations of SARS-CoV-2 in Isolated Strains from Iraq
by: Ali A. Dawood, et al.
Published: (2022-07-01)

Study of Riamilovir Activity Against SARS-CoV-2 Infection In Syrian Hamsters
by: S. V. Chepur, et al.
Published: (2021-10-01)

Vaxtherapy, a Multiphase Therapeutic Protocol Approach for Longvax, the COVID-19 Vaccine-Induced Disease: Spike Persistence as the Core Culprit and Its Downstream Effects
by: Jose Crespo-Barrios
Published: (2025-06-01)

A descriptive review on the real-world impact of Moderna, Inc. COVID-19 vaccines
by: Mary Bausch-Jurken, et al.
Published: (2024-12-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Possible Cases of SARS-CoV-2 Reinfection In Pekanbaru, Indonesia
by: Rahmat Azhari Kemal, et al.
Published: (2022-04-01)

Saline gargle collection method is comparable to nasopharyngeal/oropharyngeal swabbing for the molecular detection and sequencing of SARS-CoV-2 in Botswana
by: Kwana Lechiile, et al.
Published: (2025-07-01)

Methodology for Estimating the Basic Reproductive Number of Current Variants of the Virus SARS-CoV-2
by: A. N. Gerasimov, et al.
Published: (2024-09-01)

Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection
by: Parastoo Hosseini, et al.
Published: (2021-03-01)